Mark Alan Goldberg Immuno Gen, Inc. (IMGN) insider trading activity

Mark Alan Goldberg is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 60,720 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Mark Alan Goldberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Sale (or disposition) back to the issuer	-	60,720 Reduced 100.0%	0 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$16,870 $29.65 p/Share	569 Added 0.93%	60,720 Common Stock
Oct 30 2023	SELL Exercise of conversion of derivative security	$150,800 $15.08 p/Share	10,000 Reduced 14.25%	60,151 Common Stock
Oct 30 2023	BUY Exercise of conversion of derivative security	$147,000 $14.7 p/Share	10,000 Added 12.48%	70,151 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	$16,869 $15.87 p/Share	1,063 Added 1.74%	60,151 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$16,869 $18.87 p/Share	894 Added 1.49%	59,088 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$16,872 $3.84 p/Share	4,394 Added 7.02%	58,194 Common Stock

Also insider at

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

BPMC

Blueprint Medicines Corp Healthcare

GLYC

GLYCOMIMETICS INC Healthcare

MAG